Transfection of the mutant TRIP230 into Rb-positive MCF7 human breast cancer cells further enhanced expression of the reporter gene (Figure 6F), thus acting as a dominant negative likely by competing for HREs with the endogenous wild-type TRIP230. The gene discussed is RB1; the disease is breast cancer.